510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K112125Substantially Equivalent

Illumigene Group B Streptococcus ,External Control Kit

Meridian Bioscience Inc, Cincinnati OH / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K112125 is the FDA 510(k) clearance record for ILLUMIGENE GROUP B STREPTOCOCCUS ,EXTERNAL CONTROL KIT, a class I device, cleared for Meridian Bioscience, Inc. on under FDA product code NJR (Nucleic Acid Amplification Assay System, Group B Streptococcus, Direct Specimen Test). FDA's definition for product code NJR reads: "A nucleic acid amplification assay system (including probes, other reagents, and instrumentation) is an aid in the identification of group b streptococci from pre-partum and intra-partum women to establish colonization status". FDA records list 38 510(k) clearances for Meridian Bioscience, Inc., from to . As of , FDA records show no recalls naming K112125.

Clearance record

Decision date
Received
(133 days to decision)
Product code
NJR Nucleic Acid Amplification Assay System, Group B Streptococcus, Direct Specimen Test
Regulation
21 CFR 866.3740
Device class
Class I
Review panel
Microbiology
Applicant
Meridian Bioscience, Inc. 3471 River Hills Dr., Cincinnati OH
510(k) summary
Summary PDF
Third party review
No

Clearances, product code NJR

Trailing 12 months

FDA records hold no clearances under product code NJR in the trailing twelve months.

FDA records show no clearances under product code NJR in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code NJR, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260